UPI Key Stats
- Unusual 11 Mid-Day Movers 06/14: (BCSB) (RH) (CDXS) Higher; (CEMP) (OSH) (WLT) L... Jun 14
- Uroplasty (UPI) to Delay 10-K Filing Street Insider Jun 14
- JMP Securities Upgrades Uroplasty (UPI) to Market Outperform Street Insider May 31
- Uroplasty's CEO Discusses F4Q 2013 Results - Earnings Call Transcript Seeking Alpha May 30
- Uroplasty, Inc. Earnings Call scheduled for 4:30 pm ET today May 30
- Uroplasty, Inc. (UPI) Announces Positive Coverage Decision For Percutaneous Tibi... May 30
- Uroplasty, Inc. (UPI) Posts Q4 Loss of 5c/Share Street Insider May 30
- Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Sti... May 30
- Uroplasty Reports Fiscal Fourth Quarter And Full Year 2013 Financial Results PR Newswire May 30
- UROPLASTY INC Files SEC form 8-K, Results of Operations and Financial Condition May 30
UPI Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Uroplasty is down 38.42% over the last year vs S&P 500 Total Return up 24.84%, Abiomed down 1.85%, and Solei Systems down 22.22%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for UPI
Pro Strategies Featuring UPI
Did Uroplasty make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.